2596
H.A. Ioannidou, P.A. Koutentis / Tetrahedron 68 (2012) 2590e2597
132 ꢀC until no starting material remained (TLC). The reaction
mixture was then allowed to cool to ca. 20 ꢀC, diluted (DCM) and
adsorbed onto silica. Chromatography (hexane/DCM, 1:1) gave the
title compound 22 (35.6 mg, 79%) as yellow needles; mp (DSC) onset
213.2 ꢀC, peak 214.5 ꢀC (from pentane/DCM, 0 ꢀC); Rf 0.40 (hexane/
DCM, 1:1). Found: C, 68.86; H, 3.15; N, 17.73. C18H10N4S requires C,
4.16. Ethyl 2-(3,5-diphenyl-4H-1,2,6-thiadiazin-4-ylidene)
acetate (26)
To a stirred solution of 3,5-diphenyl-4H-1,2,6-thiadiazine-4-
thione (21) (100 mg, 0.355 mmol) in PhMe (4 mL) at ca. 20 ꢀC was
added ethyl diazoacetate (56 mL, 0.533 mmol) and the reaction
68.77; H, 3.21; N, 17.82%; lmax (DCM)/nm 261 (log
3
3.31), 381
mixture was stirred at this temperature until no starting material
remained (TLC). The reaction mixture was then diluted with DCM
(20 mL) and adsorbed onto silica. Chromatography (hexane/DCM,
1:1) gave the title compound 26 as yellow plates; mp (DSC) onset
82.0 ꢀC, peak 84.0 ꢀC (from pentane, at ca. 0 ꢀC); Rf 0.41 (hexane/
DCM, 1:1). Found: C, 67.73; H, 4.85; N, 8.28. C19H16N2O2S requires
(2.91), 445 (3.07); nmax/cmꢁ1 3046w (Ar CH), 2218m (C^N), 1512s,
1491w, 1477s, 1439s, 1343s, 1277m, 1177w, 1159w, 1103w, 1078w,
1028w, 999w, 966w, 939w, 920w, 837w, 818s, 797m, 775m; dH
(500 MHz; CDCl3) 7.87 (4H, br s, Ph H), 7.59 (6H, br s, Ph H); dC
(125 MHz; CDCl3) 150.4 (s), 142.7 (s), 134.7 (s), 132.1 (d), 129.5 (d),
127.8 (d), 111.8 (s, C^N), 79.0 [s, C(C^N)2]; m/z (EI) 314 (Mþ, 23%),
288 (5), 210 (9), 177 (16), 167 (15), 149 (100), 138 (9), 125 (7), 121
(10), 113 (14), 111 (14), 105 (10), 99 (12), 97 (17), 93 (10), 84 (41), 77
(12), 71 (41), 57 (56), 51 (21). Further elution (DCM) gave a mixture
of two purple compounds, which could not be separated or
characterized.
C, 67.84; H, 4.79; N, 8.33%; lmax(DCM)/nm 242 (log
3
3.61), 253
inf (3.58), 276 inf (3.40), 380 (3.39), 385 inf (3.36); nmax/cmꢁ1
3059w (Ar CH), 2982w, 2938w, 2901w, 1703s (C]O), 1599w,
1512w, 1489w, 1472w, 1439m, 1395w, 1368w, 1354m, 1315w,
1267s, 1180w, 1153w, 1123w, 1078w, 1036m, 1007w, 966w, 930w,
876m, 833w, 806w, 776m; dH (500 MHz; CDCl3) 7.96 (2H, d, J 5.0,
Ph H), 7.89 (2H, d, J 7.0, Ph H), 7.48 (3H, br s, Ph H), 7.42e7.40 (3H,
m, Ph H), 3.72 (2H, q, J 7.0, CH2), 0.93 (3H, t, J 7.0, CH3); dC
(125 MHz; CDCl3) 165.3 (s), 152.3 (s), 152.2 (s), 137.8 (s), 135.5 (s),
132.1 (s), 130.7 (d), 130.0 (d), 129.0 (d), 128.7 (d), 128.0 (d), 126.0
(d), 116.6 (d, CHCO2Et), 60.8 (CH2), 13.7 (CH3); m/z (EI) 336 (Mþ,
21%), 307 (9), 291 (6), 262 (100), 216 (3), 204 (2), 185 (9), 160
(55), 133 (8), 121 (5), 116 (13), 109 (10), 103 (7), 89 (8), 77 (19), 65
(7), 51 (8).
4.14. 2-(3,5-Diphenyl-4H-1,2,6-thiadiazin-4-ylidene)
malononitrile (22) and 3,5-diphenyl-4H-1,2,6-thiadiazine-4-
thione oxide (23)
To a stirred solution of 3,5-diphenyl-4H-1,2,6-thiadiazine-4-
thione (20) (100 mg, 0.355 mmol) in PhMe (2 mL) was added
TCNEO (61.3 mg, 0.426 mmol) and the reaction mixture was heated
at ca. 110 ꢀC until no starting material remained (TLC). The reaction
mixture was then allowed to cool to ca. 20 ꢀC, diluted (DCM) and
adsorbed onto silica. Chromatography (hexane/DCM, 1:1) gave the
title compound 22 (88 mg, 79%) as yellow needles; mp (DSC) onset
213.2 ꢀC, peak 214.5 ꢀC (from pentane/DCM, 0 ꢀC), identical to that
described above. Further elution (hexane/DCM, 1:1) gave the title
compound 23 (13.2 mg, 12%) as red flakes; mp 124e125.5 ꢀC (from
pentane/EtOH, at ca. 0 ꢀC); Rf 0.50 (hexane/DCM, 1:1). Found: C,
60.33; H, 3.29; N, 9.31. C15H10N2OS2 requires C, 60.38; H, 3.38; N,
Acknowledgements
The authors thank the Cyprus Research Promotion Foundation
(grant nos. ENISX/0504/08 and NEKYP/0308/02) for financial
support. Furthermore, the authors thank the following organiza-
tions in Cyprus for generous donations of chemicals and glassware:
the State General Laboratory, the Agricultural Research Institute,
the Ministry of Agriculture, MedoChemie Ltd and Biotronics Ltd.
Finally, we thank the A.G. Leventis Foundation for helping to es-
tablish the NMR facility in the University of Cyprus.
9.39%; lmax(DCM)/nm 251 (log 3.18), 284 (3.02), 426 (2.90); nmax/
3
cmꢁ1 3059w (Ar CH), 1483w, 1437w, 1321m, 1302w, 1269w, 1165w,
1142w, 1082s, 1074m, 1030w, 999w, 986w, 922w, 841w, 793m,
770m; dH (500 MHz; CDCl3) 7.95 (2H, d, J 7.0, Ph H), 7.77e7.75 (2H,
m, Ph H), 7.56e7.47 (6H, m, Ph H); dC (125 MHz; CDCl3) 166.0 (s),
153.5 (s), 153.45 (s), 136.2 (s), 135.1 (s), 132.0 (d), 131.1 (d), 129.3 (d),
128.4 (d), 128.0 (d), 127.3 (d); m/z (EI) 298 (Mþ, 100%), 281 (75), 269
(15), 265 (15), 249 (8), 220 (11), 205 (7), 190 (11), 175 (21), 167 (8),
149 (13), 146 (10), 135 (15), 121 (31), 103 (38), 89 (10), 77 (49), 63
(11), 51 (29).
References and notes
1. Breining, T.; Cimpoia, A. R.; Mansour, T. S.; Cammack, N.; Hopewell, P.; Ashman,
C. Heterocycles 1995, 41, 87e94.
2. McKendry, L. H.; Bland, W. P. U.S. Patent. 4,155,746, 1979.
3. Wigand, R.; Guerra, J. M. J. Photochem. Photobiol., A: Chem. 1995, 88, 35e38.
€
4. Hamprecht, G.; Konig, K.-H.; Stubenrauch, G. Angew. Chem., Int. Ed. Engl. 1981,
20, 151e164.
5. Moody, C. J. In; Katritzky, A. R., Rees, C. W., Eds. Comprehensive Heterocyclic
Chemistry; Pergamon: Oxford, 1984; Vol. 3, p 1039.
6. Smalley, R. K. In; Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds. Compre-
hensive Heterocyclic Chemistry II; Pergamon: Oxford, 1996; Vol. 6, p 695.
7. Geevers, J.; Trompen, W. P. Recl. Trav. Chim. Pays-Bas 1974, 93, 270e272.
8. Koutentis, P. A.; Rees, C. W.; White, A. J. P.; Williams, D. J. Chem. Commun. 2000,
303e304.
4.15. 2-(3,5-Dithien-2-yl-4H-1,2,6-thiadiazin-4-ylidene)
malononitrile (24)
9. Koutentis, P. A.; Rees, C. W. J. Chem. Soc., Perkin Trans. 1 2000, 1081e1088.
10. Koutentis, P. A.; Rees, C. W. J. Chem. Soc., Perkin Trans. 1 2000, 1089e1094.
11. Koutentis, P. A.; Rees, C. W. J. Chem. Soc., Perkin Trans. 1 2000, 2601e2607.
12. Kalogirou, A. S.; Koutentis, P. A.; Rikkou, M. D. Tetrahedron 2010, 66, 1817e1820.
13. Ioannidou, H. A.; Kizas, C.; Koutentis, P. A. Org. Lett. 2011, 13, 3466e3469.
14. Peake, C. J.; Harnish, W. N.; Davidson, B. L. U.S. Patent 4,100,281, 1978.
15. Peake, C. J.; Harnish, W. N.; Davidson, B. L. U.S. Patent 4,143,138, 1979.
16. Peake, C. J.; Harnish, W. N.; Davidson, B. L. U.S. Patent 4,201,780, 1980.
17. Portnoy, R. C. U.S. Patent 4,497,807, 1985.
Following the procedure described for compound 22 treatment
of 3,5-dithien-2-yl-4H-1,2,6-thiadiazine-4-thione (21) (105 mg,
0.355 mmol) gave the title compound 24 (91.5 mg, 79%) as red
needles; mp 217e220 ꢀC (from cyclohexane); Rf 0.25 (hexane/DCM,
7:3). Found: C, 51.42; H, 1.83; N, 17.09. C14H6N4S3 requires C, 51.51;
H, 1.85; N, 17.16%; lmax(DCM)/nm 259 inf (log
3
3.45), 281 (3.63),
18. Flowerday, P.; Perkins, M. J. Tetrahedron Lett. 1968, 9, 1261e1264.
19. Flowerday, P.; Perkins, M. J.; Arthur, A. R. J. J. Chem. Soc. C 1970, 290e297.
20. Haddon, R. C.; Kaplan, M. L.; Marshall, J. H. J. Am. Chem. Soc. 1978, 100,
1235e1239.
422 (3.41), 484 (3.29); nmax/cmꢁ1 3111w and 3094w (Ar CH), 2218m
(C^N), 1520m, 1505s, 1452m, 1439m, 1418s, 1348m, 1337w, 1287w,
1248w, 1225w, 1109w, 1057w, 907w, 858m, 851m, 828w, 816m; dH
(500 MHz; CDCl3) 7.66 (2H, d, J 5.0, thienyl H), 7.58 (2H, d, J 3.5,
thienyl H), 7.19 (2H, dd, J 4.3, 4.3, thienyl H-4); dC (125 MHz; CDCl3)
142.7 (s), 142.0 (s), 138.0 (s), 133.0 (d), 129.7 (d), 128.0 (d), 111.8
(C^N), 78.6 (s); m/z (EI) 326 (Mþ, 100%), 293 (44), 277 (4), 249 (4),
217 (7), 171 (60), 149 (12), 144 (12), 127 (12), 115 (8), 109 (46), 97 (8),
82 (11), 69 (29), 58 (23).
ꢀ
21. Gomez, T.; Macho, S.; Miguel, D.; Neo, A. G.; Rodríguez, T.; Torroba, T. Eur. J. Org.
Chem. 2005, 5055e5058.
22. Macho, S.; Miguel, D.; Neo, A. G.; Rodríguez, T.; Torroba, T. Chem. Commun.
2005, 334e336.
23. Ioannidou, H. A.; Kizas, C.; Koutentis, P. A. Org. Lett. 2011, 13, 5886e5889.
24. Cava, M. P.; Lakshmikantham, M. V.; Hoffmann, R.; Williams, R. M. Tetrahedron
2011, 67, 6771e6797.
25. Posner, G. H.; Loomis, G. L.; Sawaya, H. S. Tetrahedron Lett. 1975, 16, 1373e1376.